ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,083.48
-0.02%
Dow Jones
43,408.47
0.32%
Gold vs US Dollar
2,667.41
0.56%
Brent Oil
73.54
0.96%
Bitcoin
97,657.41
3.50%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) News

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:POLB
DateTimeSourceHeadlineSymbolCompany
20/11/202418:26Alliance NewsAlliance NewsPoolbeg Pharma granted US patent for influenza treatmentLSE:POLBPoolbeg Pharma Plc
20/11/202418:26Alliance NewsAlliance NewsPoolbeg Pharma granted US patent for influenza treatmentLSE:POLBPoolbeg Pharma Plc
20/11/202407:00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 Patent Granted in United StatesLSE:POLBPoolbeg Pharma Plc
06/11/202407:00RNS Non-RegulatoryPoolbeg Pharma PLC POLB 001 data to be presented at ASHLSE:POLBPoolbeg Pharma Plc
18/09/202406:00RNS Regulatory NewsPoolbeg Pharma PLC Interim results for the six months to 30 June 2024LSE:POLBPoolbeg Pharma Plc
27/08/202406:00RNS Non-RegulatoryPoolbeg Pharma PLC H.C. Wainwright Global Investment ConferenceLSE:POLBPoolbeg Pharma Plc
12/08/202412:28RNS Regulatory NewsPoolbeg Pharma PLC Holding(s) in CompanyLSE:POLBPoolbeg Pharma Plc
26/07/202417:59Alliance NewsAlliance NewsEARNINGS AND TRADING: Man Group profit rises; Petershill AUM increasesLSE:POLBPoolbeg Pharma Plc
26/07/202417:59Alliance NewsAlliance NewsEARNINGS AND TRADING: Man Group profit rises; Petershill AUM increasesLSE:POLBPoolbeg Pharma Plc
26/07/202406:00RNS Regulatory NewsPoolbeg Pharma PLC Voluntary Delisting from OTCQB MarketLSE:POLBPoolbeg Pharma Plc
10/07/202406:00RNS Regulatory NewsPoolbeg Pharma PLC Notification of Major HoldingsLSE:POLBPoolbeg Pharma Plc
02/07/202406:00RNS Regulatory NewsPoolbeg Pharma PLC Change of Registered AddressLSE:POLBPoolbeg Pharma Plc
17/06/202407:38RNS Regulatory NewsPoolbeg Pharma PLC Result of AGMLSE:POLBPoolbeg Pharma Plc
09/05/202406:00RNS Regulatory NewsPoolbeg Pharma PLC Annual Report & AGM NoticeLSE:POLBPoolbeg Pharma Plc
01/05/202415:39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202415:39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202406:00RNS Regulatory NewsPoolbeg Pharma PLC Significant POLB 001 Patent Granted in USALSE:POLBPoolbeg Pharma Plc
30/04/202415:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202415:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202406:02RNS Regulatory NewsPoolbeg Pharma PLC Appointment of Joint BrokerLSE:POLBPoolbeg Pharma Plc
30/04/202406:01RNS Regulatory NewsPoolbeg Pharma PLC Option Agreement to Acquire Orphan Drug CandidateLSE:POLBPoolbeg Pharma Plc
30/04/202406:00RNS Regulatory NewsPoolbeg Pharma PLC Results for the year ended 31 December 2023LSE:POLBPoolbeg Pharma Plc
29/04/202406:00RNS Regulatory NewsPoolbeg Pharma PLC TR-1: Notification of major holdingsLSE:POLBPoolbeg Pharma Plc
20/03/202416:18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202416:18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202407:00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 US Patent UpdateLSE:POLBPoolbeg Pharma Plc
22/02/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Director/PDMR ShareholdingLSE:POLBPoolbeg Pharma Plc
19/02/202413:42RNS Regulatory NewsPoolbeg Pharma PLC Director Share PurchaseLSE:POLBPoolbeg Pharma Plc
15/02/202416:02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202416:02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
 Showing the most relevant articles for your search:LSE:POLB

Your Recent History

LSE
IHG
Intercontinental Hotels
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06